| abstract |
Antibodies that bind CSF1R are provided. Also provided are heavy and light chains of antibodies capable of generating antibodies that bind CSF1R. Also provided are polynucleotides encoding antibodies to CSF1R. Also provided are polynucleotides encoding heavy and light chains of antibodies. Proposed uses for the treatment of diseases using antibodies to CSF1R. Such uses include, but are not limited to, uses for the treatment of rheumatoid arthritis, osteoporosis, and multiple sclerosis. |